← Back to Search

Behavioral Intervention

Hearing Aids for Auditory Processing Disorder

N/A
Waitlist Available
Led By Melissa A Papesh, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Conductive hearing loss or other significant otologic problems
Non-native English speakers
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 2- and 6-months post randomization
Awards & highlights
No Placebo-Only Group

Summary

This trial will explore if hearing aids help those without hearing loss. It could help tailor hearing aid use to those who may benefit most.

Who is the study for?
This trial is for Veterans with normal hearing sensitivity who still experience communication difficulties. They must be eligible for VA Healthcare, able to visit the VA Portland Medical Center often, and have a moderate to significant perceived hearing handicap but no major ear problems or severe hearing loss.
What is being tested?
The study tests if using hearing aids can help veterans without hearing loss by providing slight amplification or features like noise reduction and sound streaming. It also includes communication counseling and remote microphones to see which methods are most beneficial.
What are the potential side effects?
While not explicitly stated, potential side effects may include discomfort from wearing the devices, possible dependency on them for better hearing, or an initial adjustment period with varied listening experiences.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have hearing loss or ear problems.
Select...
English is not my first language.
Select...
I cannot do the tasks required in the study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 2- and 6-months post randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 2- and 6-months post randomization for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Hearing Handicap Inventory for Adults (HHIA) score

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Hearing Aids with Remote MicrophonesExperimental Treatment3 Interventions
Individuals randomized to this group will receive communication counseling as well as hearing aids set to provide a low level of amplification and remote microphones that can be used in some situations to improve the signal-to-noise ratio.
Group II: Hearing AidsExperimental Treatment2 Interventions
Individuals randomized to this group will receive communication counseling as well as hearing aids set to provide a low level of amplification.
Group III: Communication CounselingActive Control1 Intervention
Individuals randomized to this group will receive information on how to improve their ability to hear and communicate including tips on environmental modification and communication repair strategies.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hearing Aids
2016
Completed Phase 3
~370

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,658 Previous Clinical Trials
3,361,506 Total Patients Enrolled
Melissa A Papesh, PhDPrincipal InvestigatorVA Portland Health Care System, Portland, OR
~95 spots leftby Oct 2027